United Kingdom
The Biotechnology company in United Kingdom with the highest Capital Expenditure To Sales is Freeline Therapeutics Holdings Plc (NASDAQ: FRLN) at 120.00%.
The Biotechnology company in United Kingdom with the lowest Capital Expenditure To Sales is Bicycle Therapeutics Ltd (NASDAQ: BCYC) at 0.06%.
The top 10 Biotechnology companies in United Kingdom by Capital Expenditure To Sales are Freeline Therapeutics Holdings Plc, Exscientia Ltd ADR, Roivant Sciences Ltd, Centessa Pharmaceuticals PLC ADR and Bicycle Therapeutics Ltd.
The bottom 10 Biotechnology companies in United Kingdom by Capital Expenditure To Sales are Bicycle Therapeutics Ltd, Centessa Pharmaceuticals PLC ADR, Roivant Sciences Ltd, Exscientia Ltd ADR and Freeline Therapeutics Holdings Plc.